Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) from a hold rating to a sell rating in a report published on Wednesday. A number of other research firms have also weighed in on AKBA. Jefferies Financial Group assumed coverage on Akebia Therapeutics in a research note on Tuesday. They issued a “buy” rating […]
